Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Mário Gomes-Pereira
Has grant
Senior Research Scientist (Directeur de Recherche)
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Sleep alterations in mouse models of DM1
Open Date: 2026-01-01
Close Date: 2027-12-01
Grant: Open
Gene therapy for CNS dysfunction in DM1: from cell-specific mechanisms to reversible symptoms and pre-clinical assessment of therapeutic strategies
Open Date: 2026-01-01
Close Date: 2033-01-01
Grant: Open
Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy
Open Date: 2025-03-01
Close Date: 2029-02-01
Grant: Open
RNA biology and neuroglial function: resolving the cellular and subcellular transcriptome in myotonic dystrophy brains, towards new brain gene therapy
Open Date: 2025-03-01
Close Date: 2027-02-01
Grant: Open
Brain-specific magnetic resonance biomarkers of myotonic dystrophy type 1
Open Date: 2025-01-01
Close Date: 2028-12-01
Articles (3)
Year:
2025
Year:
2025
Aims Myotonic dystrophy type I (DM1) is one of the most frequent muscular dystrophies in adults. Although DM1 has long been considered mainly a muscle disorder, growing evidence suggests the involvement of peripheral nerves in the pathogenicity of DM1 raising the question of whether motoneurons (MNs) actively contribute to neuromuscular defects in DM1. Methods By using micropatterned 96‐well plates as a coculture platform, we generated a functional neuromuscular model combining DM1 and muscleblind protein ( MBNL ) knock‐out human‐induced pluripotent stem cells‐derived MNs and human healthy skeletal muscle cells. Results This approach led to the identification of presynaptic defects which affect the formation or stability of the neuromuscular junction at an early developmental stage. These neuropathological defects could be reproduced by the loss of RNA‐binding MBNL proteins, whose loss of function in vivo is associated with muscular defects associated with DM1. These experiments indicate that the functional defects associated with MNs can be directly attributed to MBNL family proteins. Comparative transcriptomic analyses also revealed specific neuronal‐related processes regulated by these proteins that are commonly misregulated in DM1. Conclusions Beyond the application to DM1, our approach to generating a robust and reliable human neuromuscular system should facilitate disease modelling studies and drug screening assays.
Year:
2023
Collaborators (4)
Edwin Chan
Professor
The Chinese University of Hong Kong (CUHK)
Ariadna Bargiela
Junio Principal Investigator
INCLIVA Health Research Institute
Cécile Martinat
-
C Andrew Frank
Professor
Iowa State University
Make your next move.
Prepare your application
Review drafts before you send them.